Skip to main content

Topic

Post-Grant Proceedings

130 published works

  1. PTAB Litigation Blog

    PGR Petitions Are “Favored”

    By Matthew Johnson

    Visit Jones Day's PTAB Litigation blog at www.ptablitigationblog.com. By Elizabeth Schrieber and Matt Johnson – In Multi-Color Corp. v. Brook & Whittle Ltd., PGR2025-00025, the PTAB declined to discretionarily deny…

  2. IP Law Watch

    PTAB Reenforces Preference for PGR

    By Connie Jaw

    The Patent Trial and Appeal Board (PTAB) recently designated a post-grant review (PGR) decision as precedential. In the decision, the Director issued a discretionary denial decision confirming that the proper…

  3. Big Molecule Watch

    Alvotech Files PGR Against Regeneron High-Dose Aflibercept Patent

    By Darlene Staines

    On September 17, 2025, Alvotech USA Inc. and Alvotech hf. (“Alvotech”) filed a Petition for Post Grant Review of U.S. Patent No. 12,168,036 (“the ‘036 patent”), assigned to Regeneron Pharmaceuticals,…

  4. PTAB Law Blog

    USPTO Withdraws June 2022 Guidance on Fintiv Denials

    By Kristen Logan

    On Friday, February 28, 2025, the United States Patent and Trademark Office (USPTO) announced the withdrawal of the June 2022 memorandum titled “Interim Procedure for Discretionary Denials in AIA Post-Grant…

  5. PTAB Litigation Blog

    PTAB Decides Concurrent IPR and PGR Petitions After Resolving Priority Date Dispute

    By Lisa Furby

    Visit Jones Day's PTAB Litigation blog at www.ptablitigationblog.com. By Lisa Furby and Anneli Kawaoka – In anticipating a dispute over whether the America Invents Act would apply, Petitioner MPL Brands…

  6. Big Molecule Watch

    Proposed USPTO Fee Changes Could Impact PGR and IPR Filing Strategies Used by Biosimilars

    By Maria C. Smith|Sabrina Poulos

    The USPTO has proposed several fee changes for implementation in 2025. If implemented, these changes will increase filing fees for Inter Partes Reviews (IPRs) and Post Grant Reviews (PGRs) by…

  7. Life Science Legal Report

    Real Parties-In-Interest: Guidance On Who Is An RPI-And Who Is Not-In Post-Grant Proceedings

    By Emily J. Greb, Maria A. Stubbings

    In a recent article, Real Parties In Interest Guidance On Who Is An RPI-And Who Is Not-In Post Grant Proceedings, linked here, Emily Greb and Maria Stubbing offer practical guidance and…

  8. Global IP & Technology Law Blog

    ITC Section 337: Tips for Avoiding Discretionary Denials at the PTAB

    By Adam Hess

    We previously wrote that a co-pending ITC Section 337 investigation virtually guarantees that the Patent Trial and Appeal Board (PTAB) will exercise its discretionary power to deny institution under 35…

  9. Patents Post-Grant

    PTAB Clarifies Director Rehearing Details

    By Scott McKeown, Scott McKeown Wolf Greenfield

    Arthrex Information Updated The USPTO requested feedback on the interim Director review process and, in response to that feedback, has updated the Arthrex Q&As. In response to questions from the public,…

  10. Life Science Legal Report

    PTAB Adds Online Public-Submission Forms

    By Bryan D. Beel

    To guide and inform the public about the Patent Trial and Appeal Board's practice surrounding post-grant proceedings, the Board periodically designates certain of its decisions as precedential or informative.  As…